| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INCYTE | 3,879,822 | 365,828,000 | 12.86% | ||
| 2 | CELGENE CORP | 3,459,298 | 361,600,000 | 12.71% | ||
| 3 | IONIS PHARMACEUTICALS INC | 7,163,172 | 262,459,000 | 9.23% | ||
| 4 | RADIUS HEALTH | 4,360,399 | 235,854,000 | 8.29% | ||
| 5 | GILEAD SCIENCES INC | 2,774,596 | 219,526,000 | 7.72% | ||
| 6 | NEUROCRINE BIOSCIE COM USD0.001 | 3,121,552 | 158,075,000 | 5.56% | ||
| 7 | ALEXION PHARMACEUTIC | 1,179,428 | 144,527,000 | 5.08% | ||
| 8 | AGIOS PHARMACEUTICALS INC | 2,649,528 | 139,948,000 | 4.92% | ||
| 9 | VERTEX PHARMACEUT | 1,415,445 | 123,441,000 | 4.34% | ||
| 10 | REGENERON PHARMACEUTICALS | 245,000 | 98,495,000 | 3.46% | ||
| 11 | TESARO INC | 974,582 | 97,692,000 | 3.43% | ||
| 12 | HALOZYME THERAPEUTICS INC | 7,379,832 | 89,148,000 | 3.13% | ||
| 13 | ALNYLAM PHARMACEUTICALS INC | 1,191,338 | 80,749,000 | 2.84% | ||
| 14 | ALDER BIOPHARMACEUTICALS INC | 1,685,150 | 55,222,000 | 1.94% | ||
| 15 | CEMPRA INC | 2,041,900 | 49,414,000 | 1.74% | ||
| 16 | SAGE THERAPEUTICS | 1,022,439 | 47,083,000 | 1.66% | ||
| 17 | KITE PHARMA INCORPORATED | 800,000 | 44,688,000 | 1.57% | ||
| 18 | MACROGENICS INC | 1,455,000 | 43,519,000 | 1.53% | ||
| 19 | JUNO THERAPEUTICS INCORPORATED | 1,405,000 | 42,164,000 | 1.48% | ||
| 20 | INTERCEPT PHARMACEUTICAL | 255,719 | 42,089,000 | 1.48% | ||
| 21 | PROTHENA CORP PLC | 350,000 | 20,990,000 | 0.74% | ||
| 22 | INTRA CELLULAR THERAPIES INC COM | 1,350,000 | 20,574,000 | 0.72% | ||
| 23 | Esperion Therapeutics Inc | 1,308,542 | 18,123,000 | 0.64% | ||
| 24 | NOVAVAX INC COM | 8,330,000 | 17,326,000 | 0.61% | ||
| 25 | PTC THERAPEUTICS INC | 1,182,912 | 16,573,000 | 0.58% | ||
| 26 | PUMA BIOTECHNOLOGY | 241,991 | 16,225,000 | 0.57% | ||
| 27 | AVEXIS INC COM | 352,800 | 14,539,000 | 0.51% | ||
| 28 | ACHILLION PHARMACEUTICALS INC COM | 1,279,340 | 10,363,000 | 0.36% | ||
| 29 | CIDARA THERAPEUTICS INC | 746,824 | 8,551,000 | 0.30% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021739, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
